4d pharma PLC (LSE:DDDD) - Share price - Overview

Stock Report

4d pharma PLC DDDD

Last Price
GBX246.00

Day Change
-6.50|-2.57%

As of 23/06/2017
16:21:38 BST | GBX
Minimum 15 Minutes Delay.

Last Close252.50p
Day Range247.92 - 247.92
Mkt Cap163.80Mil
52-Wk Range236.05 - 825.00
Yield %0.00
ISINGB00BJL5BR07
Volume806
P/E-16.17
P/SInfinity
P/CF-12.51

Share Price

Total Returns 23/06/2017

 Chg (%)  
More ...
4d pharma PLC-24.97 
FTSE 100 TR GBP-0.50
 
Financials
201420152016
More ...
Income Statement
Turnover0.000.000.00
Operating Profit-3.56-10.51-12.29
Net Profit-2.44-7.73-9.86
Reported EPS-4.93-12.62-15.21
Balance Sheet
Current Assets32.5490.1174.98
Non Current Assets6.687.2918.18
Total Assets39.2297.3993.16
Current Liabilities1.794.314.94
Total Liabilities2.174.696.67
Total Equity37.0592.7086.48
Cash Flow
Operating Cash Flow-3.92-9.07-13.53
Net Change in Cash29.55-27.0526.88
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
--------
--------

Company Profile

4d pharma PLC is a pharmaceutical company focusing on new therapeutic areas known as live biotherapeutics.

Sector

Biotechnology

Market Position

774 of 1843 Companies

Index

FTSE AIM 100 ,FTSE AIM All Share

Outlook

(03/05/2017) no outlook statement

Next Event 02/10/2017

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)0.0015.7216.88
Div Yld (E)0.003.494.13
PEG (E)0.000.471.19
ROCE-16.01191.21209.80
Op Mrgn0.00-3.75-99.88
EPS Grwth0.0045.5133.48
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanRobert Norwood
Chief Executive OfficerDuncan Peyton
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.